Sage Journals: Discover world-class research

Abstract

To investigate the association between albumin and preoperative deep vein thrombosis (DVT) in patients undergoing total joint arthroplasty (TJA). This study enrolled 2133 patients. We created the receiver operator characteristic curve to determine the cut-off values for preoperative albumin (bromocresol green method) and DVT in TJA patients. We divided the patients into groups based on the albumin cut-off value and then assessed the risk factors in a multivariate logistic regression analysis. DVT occurred in 110 cases. The cut-off value for albumin was 37.2 g/L and the area under the curve was 0.611. Multivariate logistic regression analysis revealed that the risk for DVT before TJA in patients with albumin <37.2 g/L was increased by 1.99 times (P = .001, 95% confidence interval [CI] [1.34-2.97]); albumin of 30 to 37.2 g/L group and the albumin < 30 g/L group increased by 1.9 times (P = .002, 95% CI [1.28-2.88]) and 3.25 times (P = .015, 95% CI [1.26-8.4]), respectively. The patients in the albumin of 30 to 37.2 g/L and the albumin < 30 g/L group had 1.6 times (P < .001, 95% CI [1.3-1.99] and 6.1 times (P < .001, 95% CI [3.46-10.75]), respectively, higher risk of perioperative transfusion. Patients older than 69.5 years had a 3.8-fold increased risk of preoperative DVT (P = .005, 95% CI [2.47-5.78]). Corticosteroid use had a 3 times higher risk of preoperative DVT (P = .013, 95% CI [1.26-7.2]). We found that albumin < 37.2 g/L, patients older than 69.5 years, and corticosteroid use were independent risk factors for preoperative DVT in TJA patients. Additionally, the lower the preoperative albumin level, the greater the odds of preoperative DVT formation, and the higher the risk of perioperative transfusion.

Keywords

albumin deep vein thrombosis total joint arthroplasty perioperative blood transfusion

Introduction

The frequency of total joint arthroplasty (TJA), including total hip arthroplasty (THA) and total knee arthroplasty (TKA), is expected to increase as the global population is ageing.¹ Venous thromboembolism (VTE), a collective term for deep vein thrombosis (DVT) and pulmonary embolism (PE), is one of the most common complications after TJA and it increases perioperative morbidity and mortality.² The incidence of preoperative DVT in TJA patients is as high as 17.9%³ and that in THA patients is up to 29.4%.⁴ VTE is considered a common serious complication after TJA and an important cause of morbidity and mortality, especially in hospitalized patients. After TJA, DVT incidence may reach 40% to 60% without prophylaxis and PE may occur in 0.5% to 2% of the patients.^5,6 Therefore, identifying the high-risk factors for preoperative DVT is important for managing perioperative thrombosis in TJA patients.

Albumin inhibits platelet function indirectly and exerts an antithrombotic effect.⁷ Low albumin concentration is considered an integrative index for inflammation, hypercoagulability, or disease states that predispose patients to thrombosis.^8,9 Low albumin has been found to be independently associated with an increased risk for pulmonary complications, blood transfusions, reoperation, and readmission in patients undergoing total shoulder arthroplasty.¹⁰ Zhu et al¹¹ found albumin < 35 g/L to be an independent risk factor for preoperative DVT in lower limb fractures. Tan et al¹² demonstrated that albumin < 35 g/L was a risk factor for DVT in closed patella fracture. Song et al¹³ reported low albumin levels to be an independent risk factor for preoperative DVT in patients with intertrochanteric fractures.

Most prior studies have focused on the association between low albumin and preoperative DVT in bone fracture patients, as well as the effects of low albumin on postoperative complications in TJA patients. In contrast, we hypothesized that low albumin and preoperative DVT formation were associated in osteoarthritis (OA) patients.

Materials and Methods

Inclusion and Exclusion Criteria

Inclusion criteria: Patients who (1) underwent TJA in our hospital between January 1, 2017 and December 31, 2021 and (2) were preoperatively diagnosed with OA.

Exclusion criteria: (1) A history of VTE and thrombophilia genetic disorders; (2) use of anticoagulation medications (coumarins and indandiones; factor Xa inhibitors; heparins; and direct thrombin inhibitors) and antiplatelet agents (glycoprotein platelet inhibitors, platelet aggregation inhibitors, and protease-activated receptor-1 antagonists) before admission for TJA; (3) bone fractures; (4) tumors of the joints; (5) tuberculosis or infection of the joint; and (6) no ultrasound or albumin records.

Data Collection

We accessed the electronic medical records and surgical anesthesia information systems and collected patients’ clinical data. Patients’ general information and medical records included: height, weight, body mass index, age, gender, preoperative hypertension, diabetes, coronary heart disease (CHD), chronic obstructive pulmonary disease, chronic bronchitis, OA, cerebral infarction, cancer (Cancer refers to patients who have previously suffered from malignant tumors, including breast cancer, early lung cancer, nasopharyngeal cancer, throat cancer, etc, but have now been clinically cured.), renal failure, use of corticosteroids, smoking, alcohol consumption, major surgery (major surgery requiring anesthesia [general, orthopedic, neurologic, or gynecologic surgery]¹⁴ in the previous 12 months; laboratory examinations: blood type, albumin [in bromocresol green [BCG] method] in our laboratory, and the normal reference range 40–55 g/L), the result of preoperative low extremity vein ultrasound and perioperative blood transfusions (all of our transfusions refer only to transfusions during TJA procedures and were performed in strict accordance with the transfusion guidelines¹⁵). After admission, our TJA patient underwent liver function tests followed by lower extremity venous Doppler ultrasound. Liver function tests were performed 6 to 48 h prior to lower extremity Doppler examinations.

Preoperative DVT was defined as DVT detection by Doppler ultrasound between admission and surgery. All patients were examined by Philips IE33 GE Vivid 9, C5-1, and 5 to 10 Hz pulsed Doppler ultrasound. The results were co-diagnosed by two experienced sonographers. The positive criteria for DVT by ultrasound included venous incompressibility, intravascular filling defect, and Doppler signal absence. The location of DVT was classified as follows: distal thrombosis (a previous thrombus at or below the popliteal vein), proximal thrombosis (thrombus above the popliteal vein), and mixed thrombosis (both proximal and distal). This study has been approved by Medical Research and Ethics Review (No. 184, 2022) and registered in the WHO International Clinical Trials Registration (ChiCRT2100054844).

Statistical Analysis

SPSS 26.0 was used for statistical analyses. Specifically, we created the receiver operator characteristic (ROC) curve to determine the cut-off values for preoperative albumin and age and DVT in TJA patients. The cut-off value and the area under the curve (AUC) were calculated. And then, we divided the patients into 2 groups: one above and the other below the cut-off value and risk factors were subsequently analyzed. For enumeration data, the chi-square test or Fisher's exact test was used. The results were represented in percentage (%) and DVT-related variates were analyzed. The variates that were statistically significant in the univariate analysis were included in the multivariate analysis. The adjusted odds ratio (OR) and 95% confidence interval (95% CI) were calculated, to evaluate the preoperative association of low albumin with preoperative DVT in TJA patients. P < .05 was considered statistically significant.

Results

General Information of Participants

We excluded 3 patients with a history of VTE and genetic thrombophilia; 9 patients who had received anticoagulants at some earlier time before operation; 343 patients with fractures; 25 cases of joint tumors; 19 cases of joint tuberculosis or infection; 194 cases did not have ultrasonic or albumin records before surgery. Finally, 593 patients were excluded and 2133 patients were included.

The mean age was 63.2 ± 12.1 years among all the 2133 TJA patients, 71.5 ± 8.9 years in the DVT group, and 62.7 ± 12.1 years in the non-DVT group (Table 1). The mean height was 156.58 ± 6.4 cm in the DVT group and 158.08 ± 8.33 cm in the non-DVT group. And 1001 cases underwent TKA and 1128 underwent THA. Among them, 794 (38.56%) were men and 1265 (61.44%) were women. Preoperative comorbidities were hypertension (611 cases), diabetes (206 cases), and CHD (112 cases) (Table 2).

Table 1.

Summary of Patient Characteristics.

Influencing Factor	DVT (110)	Non-DVT (2023)	P
Weight (kg)	59.9 ± 9.4	61.7 ± 10.4	.073
BMI (kg/m²)	24.5 ± 3.7	24.7 ± 3.7	.523
Age (year)	71.5 ± 8.9	62.7 ± 12.1	<.001
Albumin (g/L)	36.8 ± 3.9	38.3 ± 3.9	<.001

P < .05 was statistically significant.

Abbreviations: BMI, body mass index; DVT, deep vein thrombosis.

Table 2.

Univariate Analysis of Preoperative DVT Risk in Patients Undergoing TJA.

Influencing Factor	Chi-square Test Value	P
The grading of age	55.74	<.001
Gender	7.15	.008
Hypertension	12.75	.001
Diabetes	4.47	.045
CHD	10.05	.006
COPD	4.48	.059
Chronic bronchitis	4.16	.065
Cerebral infarction	2.78	.098
Major surgery in the past 12 months	5.01	.052
Cancer	1.32	.237
Renal failure	6.46	.060
Depression	0.22	1.000
Corticosteroid	5.35	.032
Smoking	3.65	.058
Drinking	0.47	.584
Blood type	5.71	.127
The grading of albumin	22.91	<.001
Classification of albumin	17.79	<.001

P < .05 was statistically significant.

Abbreviations: CHD, coronary heart disease; COPD, chronic obstructive pulmonary disease; DVT, deep vein thrombosis; TJA, total joint arthroplasty.

Characteristics of Patients With a Previous DVT

One hundred and ten cases (5.16%) with DVT before TJA included 81 distal thrombus cases (74%), 13 proximal thrombus cases (14.55%), and 16 mixed thrombus cases (11.82%). Low molecular weight heparin was used for the thrombus. Once proximal DVT formation (acute or nonacute DVT) was detected by preoperative lower extremity Doppler ultrasonography in patients, the inferior vena cava filter was placed before TJA. None of our TJA patients had PE during the perioperative period.

Analysis of Factors Associated With a High Risk of Preoperative DVT

The albumin was 36.8 ± 3.9 g/L in the DVT group and 38.3 ± 3.9 g/L in the non-DVT group, P < .05 (Table 1). Based on the ROC curve, we determined the cut-off value for albumin of 37.2 g/L, the AUC of 0.611 (P < .001, 95% CI [0.558-0.658]), and the cut-off value for the age of 69.5 years, the AUC of 0.723 (P < .001, 95% CI [0.68-0.76]) (Figure 1). The normal reference range for albumin in our laboratory is 40 to 55 g/L. There were 1491 TJA patients with albumin < 40 g/L, the incidence was 69.9%, and no patients with albumin >55 g/L. And 798 cases (37.41%) had albumin < 37.2 g/L before TJA; 693 patients with TJA had albumin between 37.5 and 40 g/L, with an incidence of 43.75%. Patients were divided into 3 groups based on their albumin levels: 1 group < 30 g/L, 1 group between 30 and 37.2 g/L, and 1 group > 37.2 g/L. According to the cut-off value, we grouped age: one group ≥ 69.5 years and another group < 69.5 years. Perioperative transfusion occurred in 471 cases (22.08%). As shown in Table 3, as the albumin level decreased, the incidence of DVT before TJA and perioperative transfusion increased. Where pathology laboratories use the bromocresol purple (BCP) method for albumin quantitation the calculated threshold level of 37.2 g/L will be approximately 6 g/L lower, that is 31 g/L.¹⁶

Figure 1.

Diagnostic performances of albumin for predicting DVT in patients undergoing TJA. Albumin was measured by the bromocresol green method in our laboratory, and the normal reference range was 40 to 55 g/L. P < .05 was statistically significant. Abbreviation: AUC, area under curve; CI, confidence interval; DVT, deep vein thrombosis; TJA: total joint arthroplasty.

Table 3.

Degree of Albumin and the Incidence of Preoperative DVT and Blood Transfusion in Patients Undergoing TJA.

Influencing Factor	Degree of Albumin (g/L)
Influencing Factor	<30 (52)	30–37.2 (746)	>37.2 (1335)
DVT (110)	6 (11.5%)	56 (7.5%)	48 (3.6%)
Blood transfusion (471)	30 (57.7%)	197 (26.4%)	244 (18.3%)

Abbreviations: DVT, deep vein thrombosis; TJA, total joint arthroplasty.

Analysis of High-Risk Factors of Preoperative DVT

Univariate logistic regression analysis revealed that the risk for DVT before TJA in patients with albumin <37.2 g/L was increased by 2.26 times (P < .001, 95% CI [1.53-3.33]). Compared to the albumin ≥ 37.2 g/L group, the risk for preoperative DVT in the albumin of 30 to 37.2 g/L group and the albumin < 30 g/L group increased by 2.18 (P < .001, 95% CI [1.46-3.24]) and 3.50 times (P = .006, 95% CI [1.42-8.59]), respectively. We also found that age, gender, hypertension, CHD, diabetes mellitus, and corticosteroid use were risk factors for DVT before TJA (Figure 2). Additionally, compared to the albumin ≥ 37.2 g/L group, the risk for perioperative transfusion in the albumin of 30 to 37.2 g/L group and the albumin < 30 g/L group increased by 1.6 (P < .001, 95% CI [1.30-1.99]) and 6.10 times (P < .001, 95% CI [3.46-10.75]), respectively.

Figure 2.

Univariate logistic regression analysis of preoperative risk factors for DVT in patients undergoing TJA. P < .05 was statistically significant. Abbreviations: CHD, coronary heart disease; CI, confidence interval; DVT, deep vein thrombosis; OR, odds ratio; TJA, total joint arthroplasty.

Multivariate logistic regression analysis revealed that the risk for DVT before TJA in patients with albumin < 37.2 g/L was increased by 1.99 times (P = .001, 95% CI [1.34-2.97]) (Figure 3b). Compared to the albumin ≥ 37.2 g/L group, the risk for preoperative DVT in the albumin of 30 to 37.2 g/L group and the albumin < 30 g/L group increased by 1.92 times (P = .002, 95% CI [1.28-2.88]) and 3.25 times (P = .015, 95% CI [1.26-8.41]), respectively. Patients older than 69.5 years had a 3.8-fold increased risk of preoperative DVT (P = .005, 95% CI [2.47-5.78]). Patients with corticosteroid use had an approximately 3.02 times higher risk of preoperative DVT (P = .013, 95% CI [1.26-7.2]) (Figure 3b).

Figure 3.

Multivariate logistic regression analysis of preoperative risk factors for DVT in patients undergoing TJA. (a) Multivariate logistic regression analysis of albumin and preoperative DVT in patients undergoing TJA. (b) Multivariate logistic regression analysis of degree of albumin and preoperative DVT in patients undergoing TJA. P < .05 was statistically significant. Abbreviations: CHD, coronary heart disease; CI, confidence interval; DVT, deep vein thrombosis; OR, odds ratio; TJA, total joint arthroplasty.

Discussion

In our study, 74% of clots were distal in TJA patients who had a previous DVT detected. In our series, all symptomatic DVT was essentially proximal thrombus and mixed thrombus, and the patients with distal thrombus had essentially no obvious clinical symptoms. Song et al⁴ demonstrated that 66.7% of the THA patients who were diagnosed with preoperative VTE had another thrombosis at the same sites following the THA. Small-sized thrombosis may lead to PE, hence Smith et al¹⁷ urged attention to medium and small-sized peripheral DVT in patients undergoing THA. If the patient with thrombosis underwent surgery, immobilization and other procedures, DVT may develop, extend or even detach, causing PE, severe disability, or even death.¹⁸ Therefore, we considered it important to identify any occurrence of distal DVT in clinical work.

To our knowledge, the present study is the first to demonstrate an association between albumin levels and preoperative DVT in TJA patients with OA, as well as the first study that has found that the lower the preoperative albumin value, the greater the odds of preoperative DVT being detected in TJA patients, and a higher likelihood for perioperative transfusion. As albumin is measured in the liver function tests, no extra financial burden is imposed on patients. Therefore, compared to other inflammatory cytokines, they are more clinically accessible and more advantageous in predicting DVT formation before TJA. Our findings indicate that patients who are to undergo TJA and have an albumin <37.2 (BCG albumin assay, but lower if the BCP albumin assay is used) should be aware of the potential for a previous DVT to be present. The albumin results measured by BCP and BCG methods are different. In renal failure the BCG methods are preferred.¹⁹ However, in other conditions, the BCG method produces a higher reference range.¹⁹ Coley-Grant et al¹⁶ found that constant bias of approximately + 6 g/L occurred with the BCG method compared to the BCP method. The BCG method reported by Garcia Moreina et al²⁰ is falsely elevated in patients with low serum albumin and an inflammatory condition due to raised alpha-1 and alpha-2 globulins. However, we did not find an increase in alpha-1 and alpha-2 globulins in patients with OA. Therefore, it is feasible to measure the albumin level by BCG method in TJA patients. Enoxaparin was the most commonly used low molecular weight heparin in our TJA patients. For patients who had a previous DVT, 1 mg/kg once daily, the dose of thromboprophylaxis in patients who had no previous DVT was 30 mg once daily. Enoxaparin was discontinued 12 h before surgery.²¹

Association Between Low Albumin, Age, and DVT

Albumin is the most prevalent serum protein and is a commonly used marker of nutritional status.²² It has been found that up to 50% of orthopedic patients may suffer from protein malnutrition before surgery.²³ And 27% of THA and TKA had varying degrees of low albumin, and the degree was positively correlated with age (> 60 years old).^24,25 The incidence of albumin < 37.2 g/L in our TJA patients was 37.4%. And 717 cases were older than 69.5 years old, with an incidence of 33.6%; 316 cases complicated with low albumin, accounting for 44.07% of patients older than 69.5 years. Our study found that patients older than 69.5 years had a 3.8-fold increased risk of preoperative DVT (P = .005, 95% CI [2.47-5.78]). It is also an independent risk factor for preoperative DVT formation in TJA patients. Elderly people have elevated plasma levels of factor VII, factor V antigen, fibrinogen, and D-dimer, and have a relatively prothrombotic state compared with younger adults.²⁶ Generally, age significantly affects the albumin level, primarily due to reduced nutrient absorption. The mean age of our patients was 63 years, and that in the DVT group was higher than that in the non-DVT group. Various studies demonstrated a progressive reduction of albumin serum concentration between 0.08 and 0.17 g/L per year, associated with ageing.²⁷ In addition, interleukin-6 (IL-6) and tumor necrosis factor α (TNF-α) are directly associated with lower levels of albumin in the elderly.²⁸ IL-6 and TNF-α were found in patients with OA.²⁹ Therefore, low-grade inflammation is a potential cofactor for low albumin, and this combined with advanced age together promote the formation of DVT.

Olson et al³⁰ reported that for every standard deviation drop in serum albumin, there was a 25% increase in the risk of VTE. Chi et al⁸ found that albumin < 35 g/L had 2-fold greater odds for developing VTE compared with those with albumin ≥ 42 g/L. Moghadamyeghaneh et al³¹ found that serum albumin < 35 g/L significantly increased the risk of developing postoperative DVT and PE. Zhao et al³² found that albumin < 35 g/L was significantly associated with preoperative DVT in 1515 elderly patients with intertrochanteric fracture (OR = 1.516, P = .043). Based on the ROC curve, we found the cut-off value for albumin to be 37.2 g/L, and the AUC was 0.611. This cut-off value is slightly higher than the lower end of the adult reference range for albumin. We included both age and albumin in the multivariate analysis and the results still showed albumin < 37.2 g/L was an independent risk factor for preoperative DVT in TJA patients. Moreover, the TJA patients with albumin <37.2 g/L had a 1.99 times higher risk of preoperative DVT (P = .001, 95% CI [1.34-2.97]).

Furthermore, Chi et al⁸ reported that the risk of DVT increased approximately 1.4 times for each 5.24 g/L decrease in albumin. Acutely ill hospitalized patients with low serum albumin had an increased VTE risk over 77 days.⁸ In nephrotic syndrome, Gyamlani et al³³ found that compared with patients with serum albumin ≥ 40 g/L, those with albumin levels of 30 to 39.9 g/L had a 1.5-fold risk of VTE, whereas those with serum albumin 25 to 29.9 g/L had a 2-fold higher and those with serum albumin < 25 g/L had an almost 3-fold risk of VTE. Lionaki et al³⁴ reported low albumin to be the dominant independent risk factor for VTE in patients with membranous nephropathy. In their study, 28 g/L was the threshold below which the risk of VTE increased 3.9-fold, and when the albumin level declined further to < 22 g/L, the risk of VTE increased 5.8-fold.³⁴ These studies reported that low albumin level was associated with a high risk of VTE, which is similar to the present study. Our study found that the lower the preoperative albumin level, the higher the risk of preoperative DVT. Compared to the albumin ≥ 37.2 g/L group, the risk for preoperative DVT in the albumin of 30 to 37.2 g/L group and the albumin < 30 g/L group increased by 1.92 times (P = .002, 95% CI [1.28-2.88]) and 3.25 times (P = .015, 95% CI [1.26-8.41]), respectively.

Mechanism of Low Albumin Action on Preoperative DVT in TJA Patients

Low albumin concentration is considered an integrative index for inflammation, hypercoagulability, or disease states that predispose patients to thrombosis.⁸ The mechanism for the association between low albumin and preoperative DVT in TJA patients may be 2-fold. First, low albumin may be a marker of inflammation, and inflammation can cause a hypercoagulable state in patients.³⁵ Several cytokines and chemokines have been detected in joint tissues of OA, such as IL-1, IL-6, and TNF-α.²⁹ The patients enrolled in our study had a long course of disease, varying from years to decades. Therefore, patients with OA are regarded as having a chronic and long-term inflammatory condition. Second, low albumin can lead to a hypercoagulable state in the blood. Albumin has been found to have anticoagulant properties by inhibiting fibrin polymerization and platelet aggregation.⁹ Moreover, albumin appears to enhance the effect of antithrombin III, thus exerting a heparin-like action.³⁶ Lower serum albumin may also indicate a hypercoagulable state because of its association with higher fibrinogen and factor VIII levels and a shorter activated partial thromboplastin time.³⁷ Low albumin leads to increased bioavailability of arachidonic acid and increased thromboxane A2, thereby favoring platelet aggregation and hyperactivity.⁹ This is consistent with the mechanism underlying the promoting effect of low albumin on recurrent thrombosis.

Association Between Low Albumin and Perioperative Transfusion

Total shoulder arthroplasty patients with a low albumin level during and after surgery had an increased incidence of blood transfusion. Low albumin was independently associated with an increased risk of blood transfusion.¹⁰ In hip fractures, albumin < 35 g/L indicates increased allogenic blood transfusion.³⁸ Zhu et al found that preoperatively low albumin patients had a 2.26-fold higher risk of perioperative transfusion in 414 elderly patients with femoral neck fractures who underwent hemiarthroplasty. Low albumin was an independent risk factor for blood transfusion in patients undergoing hemiarthroplasty.³⁹ In our study, when the albumin was <30 g/L, the incidence of perioperative transfusion increased to 57.7%. Our study found that preoperative albumin < 37.2 g/L was a risk factor for perioperative transfusion in TJA patients. We also found that compared to the albumin ≥ 37.2 g/L group, the likelihood for perioperative transfusion in the groups with albumin of 30 to 37.2 g/L or <30 g/L increased by 1.6 times (P < .001, 95% CI [1.30-1.99]) and 6.10 times (P < .001, 95% CI [3.46-10.75]), respectively. The lower the preoperative albumin level, the higher the risk of perioperative transfusion in TJA patients.

Moreover, we also found corticosteroid use was an independent risk factor for preoperative DVT in TJA patients. Lieber et al⁴⁰ found that corticosteroids were associated with a 1.47-fold (95% CI 1.13-1.90) increase in the risk of PE and a 1.55-fold (95% CI 1.28-1.87) increase in the risk of DVT within 30 days after surgery. Corticosteroids may disrupt the balance between procoagulant factors and antithrombotic mechanisms⁴¹ and can increase prothrombin plasma concentrations.⁴² Corticosteroid has been found to increase the levels of factors VII, VIII, XI, and fibrinogen, which may contribute to increased risk of VTE in patients with chronic corticosteroid use.⁴³ We found that corticosteroid use had a three times higher risk of preoperative DVT (P = .013, 95% CI [1.26-7.2]) in TJA patients.

However, our study has certain limitations. Some data are incomplete because the study was retrospective. The AUC for albumin was 0.611, indicating a moderate risk of identifying at-risk patients. The association between albumin and preoperative DVT in TJA patients should be further verified in future studies with larger sample sizes and more data.

Conclusion

To our knowledge, this is the first study that has demonstrated the association between low albumin and preoperative DVT in TJA patients. We found that albumin < 37.2 g/L, patients older than 69.5 years, and corticosteroid use were independent risk factors for preoperative DVT in TJA patients. Additionally, the lower the preoperative albumin value, the greater the odds of preoperative DVT being detected by Doppler ultrasound in TJA patients, and the higher the risk of perioperative transfusion.

Footnotes

Abbreviations

Author Contributions

XX,TL,SY,XL,QM,and YX contributed to the conception and design of the study. XX,TL,SY,and XL contributed to the acquisition and analysis of data. XX wrote the manuscript. QM and YX revised the manuscript. All authors read and approved the final manuscript.

Consent to Participate

As this was a retrospective study,and data were analyzed anonymously,informed consent was therefore waived by the committee.

Data Sharing Statement

The data used during the current study are available from the corresponding author on reasonable request.

Declaration of Conflicting Interests

The author(s) declared no potential conflicts of interest with respect to the research,authorship,and/or publication of this article.

Ethical Approval

This study has been approved by Medical Research and Ethics Review (No. 184,2022).

Funding

The author(s) disclosed receipt of the following financial support for the research,authorship,and/or publication of this article: This work was supported by the Medical Research Project jointly funded by the Chongqing Science and Technology Commission and the Chongqing Health Commission (2022ZDXM011).

Trial Registration

ChiCRT2100054844.

ORCID iDs

Xiaojuan Xiong

Ting Li

Shuang Yu

Yan Xiong

References

Sloan

Premkumar

Sheth

. Projected volume of primary total joint arthroplasty in the U.S., 2014 to 2030. J Bone Joint Surg Am. 2018;100(17):1455‐1460. doi:10.2106/JBJS.17.01617

Memtsoudis

Della Valle

Besculides

, et al. Risk factors for perioperative mortality after lower extremity arthroplasty: a population-based study of 6,901,324 patient discharges. J Arthroplasty. 2010;25(1):19‐26. doi:10.1016/j.arth.2008.11.010

Bala

Huddleston

3rd Goodman

, et al.

Venous thromboembolism prophylaxis after TKA: aspirin, warfarin, enoxaparin, or factor Xa inhibitors?

Clin Orthop Relat Res. 2017;475(9):2205‐2213. doi:10.1007/s11999-017-5394-6

Song

Yao

Rong

, et al. The preoperative incidence of deep vein thrombosis (DVT) and its correlation with postoperative DVT in patients undergoing elective surgery for femoral neck fractures. Arch Orthop Trauma Surg. 2016;136(10):1459‐1464. doi:10.1007/s00402-016-2535-4

Russell

Huo

. Apixaban and rivaroxaban decrease deep venous thrombosis but not other complications after total hip and total knee arthroplasty. J Arthroplasty. 2013;28(9):1477‐1481. doi:10.1016/j.arth.2013.02.016.

Wang

Chen

, et al. Deep vein thrombosis after total knee arthroplasty. J Formos Med Assoc. 2000;99(11):848‐853.

Don

Kaysen

. Serum albumin: relationship to inflammation and nutrition. Semin Dial. 2004;17(6):432‐437. doi:10.1111/j.0894-0959.2004.17603.x.

Chi

Gibson

Liu

, et al. Inverse relationship of serum albumin to the risk of venous thromboembolism among acutely ill hospitalized patients: Analysis from the APEX trial. Am J Hematol. 2019;94(1):21‐28. doi:10.1002/ajh.25296.

Mikhailidis

Ganotakis

. Plasma albumin and platelet function: relevance to atherogenesis and thrombosis. Platelets. 1996;7(3):125‐137. doi:10.3109/09537109609023571

10.

Lee

Cross

, et al. Low serum albumin levels are associated with increased 30-day cardiopulmonary complications, reoperation, and readmission rates following total shoulder arthroplasty. Iowa Orthop J. 2019;39(2):27‐34.

11.

Zhu

Chen

, et al. Incidence and locations of preoperative deep venous thrombosis (DVT) of lower extremity following tibial plateau fractures: a prospective cohort study. J Orthop Surg Res. 2021;16(1):113. Published 2021 Feb 5. doi:10.1186/s13018-021-02259-y.

12.

Tan

Wang

, et al. Prevalence and risk factors of preoperative deep venous thrombosis in closed patella fracture: a prospective cohort study. J Orthop Surg Res. 2021;16(1):404. Published 2021 Jun 23. doi:10.1186/s13018-021-02558-4.

13.

Song

Zhu

Yao

, et al. Incidence and risk factors of preoperative deep vein thrombosis in patients with intertrochanteric fractures: a retrospective study. J Orthop Surg Res. 2022;17(1):375. Published 2022 Aug 3. doi:10.1186/s13018-022-03268-1.

14.

Heit

Silverstein

Mohr

, et al. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med. 2000;160(6):809815. doi:10.1001/archinte.160.6.809

15.

Huang

Shen

, et al. Blood management of staged bilateral total knee arthroplasty in a single hospitalization period. J Orthop Surg Res. 2014;9:116. doi: 10.1186/s13018-014-0116-1

16.

Coley-Grant

Herbert

Cornes

Barlow

Ford

Gama

. The impact of change in albumin assay on reference intervals, prevalence of ‘hypoalbuminaemia’ and albumin prescriptions. Ann Clin Biochem. 2016;53(Pt 1):112‐116. doi:10.1177/0004563215599560

17.

Smith

Parvizi

Purtill

. Delayed surgery for patients with femur and hip fractures-risk of deep venous thrombosis. J Trauma. 2011;70(6):E113‐E116. doi:10.1097/TA.0b013e31821b8768

18.

Xiong

Cheng

. Preoperative risk factors for deep vein thrombosis in knee osteoarthritis patients undergoing total knee arthroplasty. J Orthop Sci. 2023;28(1):180‐187. doi:10.1016/j.jos.2021.09.016

19.

Kok

Tegelaers

van Dam

van Rijn

van Pelt

. Carbamylation of albumin is a cause for discrepancies between albumin assays. Clin Chim Acta. 2014;434:6‐10. doi:10.1016/j.cca.2014.03.035

20.

Garcia Moreira

Beridze Vaktangova

Martinez Gago

Laborda Gonzalez

Garcia Alonso

Fernandez Rodriguez

. Overestimation of albumin measured by bromocresol green vs bromocresol purple method: influence of acute-phase globulins. Lab Med. 2018;49(4):355‐361. doi:10.1093/labmed/lmy020

21.

Witt

Nieuwlaat

Clark

, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy. Blood Adv. 2018;2(22):3257‐3291. doi:10.1182/bloodadvances.2018024893.

22.

Cabrerizo

Cuadras

Gomez-Busto

, et al. Serum albumin and health in older people: review and meta analysis. Maturitas. 2015;81(1):17‐27. doi:10.1016/j.maturitas.2015.02.009.

23.

Pruzansky

Bronson

Grelsamer

Strauss

Moucha

. Prevalence of modifiable surgical site infection risk factors in hip and knee joint arthroplasty patients at an urban academic hospital. J Arthroplasty. 2014;29(2):272‐276. doi:10.1016/j.arth.2013.06.019

24.

Moon

Kim

Lee

, et al. Preoperative nutritional status of the surgical patients in Jeju. Clin Orthop Surg. 2014;6(3):350‐357. doi:10.4055/cios.2014.6.3.350.

25.

Schwarzkopf

Russell

Shea

Slover

. Correlation between nutritional status and Staphylococcus colonization in hip and knee replacement patients. Bull NYU Hosp Jt Dis. 2011;69(4):308‐311.

26.

Tsai

Cushman

Rosamond

, et al. Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE). Am J Med. 2002;113(8):636‐642. doi:10.1016/s0002-9343(02)01345-1

27.

Gom

Fukushima

Shiraki

, et al. Relationship between serum albumin level and aging in community-dwelling self-supported elderly population. J Nutr Sci Vitaminol (Tokyo). 2007;53(1):37‐42. doi:10.3177/jnsv.53.37

28.

Malafarina

Uriz-Otano

Iniesta

, et al. Sarcopenia in the elderly: diagnosis, physiopathology and treatment. Maturitas. 2012;71(2):109‐114. doi:10.1016/j.maturitas.2011.11.012

29.

van den Bosch

MHJ

van Lent

PLEM

van der Kraan

. Identifying effector molecules, cells, and cytokines of innate immunity in OA. Osteoarthritis Cartilage. 2020;28(5):532‐543. doi:10.1016/j.joca.2020.01.016

30.

Olson

Cushman

Lutsey

, et al. Inflammation markers and incident venous thromboembolism: the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort. J Thromb Haemost. 2014;12(12):1993‐2001. doi:10.1111/jth.12742

31.

Moghadamyeghaneh

Hanna

Carmichael

, et al. A nationwide analysis of postoperative deep vein thrombosis and pulmonary embolism in colon and rectal surgery. J Gastrointest Surg. 2014;18(12):2169‐2177. doi:10.1007/s11605-014-2647-5

32.

Zhao

Wang

Tian

, et al. Incidence of and risk factors for pre-operative deep venous thrombosis in geriatric intertrochanteric fracture patients [published correction appears in Int Orthop. 2022 Jan 19]. Int Orthop. 2022;46(2):351‐359. doi:10.1007/s00264-021-05215-x

33.

Gyamlani

Molnar

, et al. Association of serum albumin level and venous thromboembolic events in a large cohort of patients with nephrotic syndrome. Nephrol Dial Transplant. 2017;32(1):157‐164. doi:10.1093/ndt/gfw227

34.

Lionaki

Derebail

Hogan

, et al. Venous thromboembolism in patients with membranous nephropathy. Clin J Am Soc Nephrol. 2012;7(1):43‐51. doi:10.2215/CJN.04250511

35.

Omar

Mirsaeidi

Rashad

, et al. Association of serum albumin and severity of pulmonary embolism. Medicina (Kaunas). 2020;56(1):26. Published 2020 Jan 9. doi:10.3390/medicina56010026.

36.

Jøorgensen

Stoffersen

. Heparin like activity of albumin. Thromb Res. 1979;16(3-4):569‐574. doi:10.1016/0049-3848(79)90105-1

37.

Folsom

Lutsey

Heckbert

, et al. Serum albumin and risk of venous thromboembolism. Thromb Haemost. 2010;104(1):100‐104. doi:10.1160/TH09-12-0856

38.

Bohl

Shen

Hannon

, et al. Serum albumin predicts survival and postoperative course following surgery for geriatric hip fracture [published correction appears in J Bone Joint Surg Am. 2018 Mar 21;100(6):E41]. J Bone Joint Surg Am. 2017;99(24):2110‐2118. doi:10.2106/JBJS.16.01620

39.

Zhu

Deng

, et al. Risk factors analysis and nomogram construction for blood transfusion in elderly patients with femoral neck fractures undergoing hemiarthroplasty. Int Orthop. 2022;46(7):1637‐1645. doi:10.1007/s00264-022-05347-8

40.

Lieber

Han

Appelboom

, et al. Association of steroid use with deep venous thrombosis and pulmonary embolism in neurosurgical patients: a national database analysis. World Neurosurg. 2016;89:126‐132. doi:10.1016/j.wneu.2016.01.033

41.

Lowe

Upton

Rumley

McConnachie

O'Reilly

Watt

. Different effects of oral and transdermal hormone replacement therapies on factor IX, APC resistance, t-PA, PAI and C-reactive protein—a cross-sectional population survey. Thromb Haemost. 2001;86(2):550‐556.

42.

Oger

Alhenc-Gelas

Lacut

, et al. Differential effects of oral and transdermal estrogen/progesterone regimens on sensitivity to activated protein C among postmenopausal women: a randomized trial. Arterioscler Thromb Vasc Biol. 2003;23(9):1671‐1676. doi:10.1161/01.ATV.0000087141.05044.1F

43.

Brotman

Girod

Posch

, et al. Effects of short-term glucocorticoids on hemostatic factors in healthy volunteers. Thromb Res. 2006;118(2):247‐252. doi:10.1016/j.thromres.2005.06.006

Association Between Low Serum Albumin and Preoperative Deep Vein Thrombosis in Patients Undergoing Total Joint Arthroplasty: A Retrospective Study

Abstract

Keywords

Introduction

Materials and Methods

Inclusion and Exclusion Criteria

Data Collection

Statistical Analysis

Results

General Information of Participants

Characteristics of Patients With a Previous DVT

Analysis of Factors Associated With a High Risk of Preoperative DVT

Analysis of High-Risk Factors of Preoperative DVT

Discussion

Association Between Low Albumin, Age, and DVT

Mechanism of Low Albumin Action on Preoperative DVT in TJA Patients

Association Between Low Albumin and Perioperative Transfusion

Conclusion

Footnotes

Abbreviations

Author Contributions

Consent to Participate

Data Sharing Statement

Declaration of Conflicting Interests

Ethical Approval

Funding

Trial Registration

ORCID iDs

References